Market Size of India Diabetes Care Drugs Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.7 Billion |
| Market Size (2029) | USD 2.01 Billion |
| CAGR (2024 - 2029) | 3.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
India Diabetes Care Drugs Market Analysis
The India Diabetes Care Drugs Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
According to the study conducted by the Indian Council of Medical Research, India Diabetes (ICMR INDIAB) and published in 2023, the incidence of diabetes stands at 101 million individuals. Diabetes risk factors include race, age, obesity, physical inactivity, a poor diet, behavioral behaviors, genetics, and family history. Controlling blood sugar, blood pressure, and lipid levels can help behavioral behaviors void or postpone the onset of diabetic complications. Diabetes prevention and management pose a significant challenge in India due to several issues and barriers, including a lack of a multisectoral approach, surveillance data, awareness of diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, and so on.
This increase in the use of diabetes medications in India can be attributed to several factors. Firstly, there has been a growing awareness about diabetes and its complications among the general population, leading to more people seeking medical help and treatment for the condition. Additionally, advancements in diabetes drug treatments have made it easier for healthcare providers to manage the disease effectively.
The availability of a wide range of diabetes medications, including oral medications, insulin injections, and newer classes of drugs such as SGLT-2 inhibitors and GLP-1 receptor agonists, has provided healthcare providers with more options to tailor treatment plans to individual patient needs. This has resulted in better glycemic control and improved outcomes for many diabetic patients.
Furthermore, the increasing prevalence of diabetes in India has also led to a greater emphasis on preventive measures and early intervention, prompting more people to seek medical advice and start treatment at an earlier stage of the disease. This proactive approach has helped to reduce the burden of diabetes-related complications and improve the overall quality of life for diabetic individuals in India.
Overall, the rise in the use of diabetes medications in India is a positive development that reflects the growing awareness and understanding of diabetes as a chronic disease that requires ongoing management and treatment. With continued advancements in diabetes drug treatments and increased access to healthcare services, the diabetic population in India can look forward to better outcomes and improved quality of life in the years to come.
